Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Sodium Valproate Medication in Epilepsy
NCT07046676Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of the University of South China
- Start
- Dec 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valproic acid in epilepsy, sponsored by The First Affiliated Hospital of the University of South China. Started Dec 2022; status: recruiting.
02
Drugs
valproic acid
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT07046676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07046676.